Local and systemic inflammatory lipid profiling in a rat model of osteoarthritis with metabolic dysregulation

por de Visser, H. M., Mastbergen, S. C., Ravipati, S., Welsing, P. M. J., Pinto, F. C., Lafeber, F. P. J. G., Chapman, V., Barrett, D. A., Weinans, H.
Publicado 2018

Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review

por Verhoeven, M. M. A., Welsing, P. M. J., Bijlsma, J. W. J., van Laar, J. M., Lafeber, F. P. J. G., Tekstra, J., Jacobs, J. W. G.
Publicado 2019

Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study

por van Helvoort, E. M., Popov-Celeketic, J., Eijkelkamp, N., Coeleveld, K., Tryfonidou, M. A., Wijne, C. D., Hack, C. E., Lafeber, F. P. J. G., Mastbergen, S. C.
Publicado 2019

IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model

por van Helvoort, E.M., de Visser, H.M., Lafeber, F.P.J.G., Coeleveld, K., Versteeg, S., Weinans, H.H, Popov-Celeketic, J., Eijkelkamp, N., Mastbergen, S.C.
Publicado 2021

The catabolic-to-anabolic shift seen in the canine osteoarthritic cartilage treated with knee joint distraction occurs after the distraction period

por Teunissen, M., Meij, B.P., Snel, L., Coeleveld, K., Popov-Celeketic, J., Ludwig, I.S., Broere, F., Lafeber, F.P.J.G., Tryfonidou, M.A., Mastbergen, S.C.
Publicado 2022

Knee Joint Distraction Compared to Total Knee Arthroplasty for Treatment of End Stage Osteoarthritis: Simulating Long-Term Outcomes and Cost-Effectiveness

por van der Woude, J. A. D., Nair, S. C., Custers, R. J. H., van Laar, J. M., Kuchuck, N. O., Lafeber, F. P. J. G., Welsing, P. M. J.
Publicado 2016

Knee joint distraction compared with high tibial osteotomy: a randomized controlled trial

por van der Woude, J. A. D., Wiegant, K., van Heerwaarden, R. J., Spruijt, S., van Roermund, P. M., Custers, R. J. H., Mastbergen, S. C., Lafeber, F. P. J. G.
Publicado 2016

IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10

por Steen‐Louws, C., Hartgring, S. A. Y., Popov‐Celeketic, J., Lopes, A. P., de Smet, M. B. M., Eijkelkamp, N., Lafeber, F. P. J. G., Hack, C. E., van Roon, J. A. G.
Publicado 2018

Can optical spectral transmission assess ultrasound-detected synovitis in hand osteoarthritis?

por Besselink, N. J., Jacobs, J. W. G., Westgeest, A. A. A., van der Meijde, P., Welsing, P. M. J., Marijnissen, A. C. A., Lafeber, F. P. J. G., Van Spil, W. E.
Publicado 2019

The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial

por Jurgens, M. S., Safy-Khan, M., de Hair, M. J. H., Bijlsma, J. W. J., Welsing, P. M. J., Tekstra, J., Lafeber, F. P. J. G., Sasso, E. H., Jacobs, J. W. G.
Publicado 2020

A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients

por Nair, S. C., Welsing, P. M. J., Choi, I. Y. K., Roth, J., Holzinger, D., Bijlsma, J. W. J., van Laar, J. M., Gerlag, D. M., Lafeber, F. P. J. G., Tak, P. P.
Publicado 2016

Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-ta...

por Besselink, N. J., Westgeest, A. A. A., Klaasen, R., Gamala, M., van Woerkom, J. M., Tekstra, J., Verhoeven, M. M. A., Van Spil, W. E., Lafeber, F. P. J. G., Marijnissen, A. C. A., Van Laar, J. M., Jacobs, J. W. G.
Publicado 2019